National Institute on Drug Abuse; Notice of Closed Meeting, 21527 [2024-06618]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 61 / Thursday, March 28, 2024 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W248, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Shree Ram Singh, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W248, Rockville,
Maryland 20850, 240–672–6175, singhshr@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–7: NCI
Clinical and Translational Cancer Research.
Date: May 17, 2024.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W640, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Saejeong J. Kim, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W640, Rockville,
Maryland 20850, 240–276–7684,
saejeong.kim@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–1: NCI
Clinical and Translational Cancer Research.
Date: May 23, 2024.
Time: 9:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W248, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Shree Ram Singh, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W248, Rockville,
Maryland 20850, 240–672–6175, singhshr@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel SEP–3; NCI
Clinical and Translational Cancer Research.
Date: June 5, 2024.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W612, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Prashant Sharma, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W612, Rockville,
Maryland 20850, 240–275–6351,
prashant.sharma@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
VerDate Sep<11>2014
20:27 Mar 27, 2024
Jkt 262001
Cancer Control, National Institutes of Health,
HHS)
Dated: March 22, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
21527
Dated: March 25, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–06618 Filed 3–27–24; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2024–06548 Filed 3–27–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
National Institutes of Health
[Docket No. USCG–2024–0233]
National Institute on Drug Abuse;
Notice of Closed Meeting
Information Collection Request to
Office of Management and Budget;
OMB Control Number: 1625–0011
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NIDA.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute on Drug Abuse,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDA.
Date: May 7, 2024.
Closed: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Date: May 8, 2024.
Closed: 9:15 a.m. to 3:55 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Date: May 9, 2024.
Closed: 9:30 a.m. to 3:20 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Drug Abuse,
NIH, Biomedical Research Center, 251
Bayview Boulevard, Baltimore, MD 21224
(Virtual Meeting).
Contact Person: Megan E. Bollinger, M.S.,
Management Analyst, Office of the Scientific
Director, National Institute on Drug Abuse,
251 Bayview Boulevard, Suite 200,
Baltimore, MD 21224, (443) 740–2466,
Megan.Bollinger@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Coast Guard, DHS.
Sixty-Day notice requesting
comments.
AGENCY:
ACTION:
In compliance with the
Paperwork Reduction Act of 1995, the
U.S. Coast Guard intends to submit an
Information Collection Request (ICR) to
the Office of Management and Budget
(OMB), Office of Information and
Regulatory Affairs (OIRA), requesting an
extension of its approval for the
following collection of information:
1625–0011, Applications for Private
Aids to Navigation and for Class I
Private Aids to Navigation on Artificial
Islands and Fixed Structures; without
change.
Our ICR describes the information we
seek to collect from the public. Before
submitting this ICR to OIRA, the Coast
Guard is inviting comments as
described below.
DATES: Comments must reach the Coast
Guard on or before May 28, 2024.
ADDRESSES: You may submit comments
identified by Coast Guard docket
number [USCG–2024–0233] to the Coast
Guard using the Federal eRulemaking
Portal at https://www.regulations.gov.
See the ‘‘Public participation and
request for comments’’ portion of the
SUPPLEMENTARY INFORMATION section for
further instructions on submitting
comments.
A copy of the ICR is available through
the docket on the internet at https://
www.regulations.gov. Additionally,
copies are available from: Commandant
(CG–6P), Attn: Paperwork Reduction
Act Manager, U.S. Coast Guard, 2703
Martin Luther King Jr. Ave. SE, Stop
7710, Washington, DC 20593–7710.
FOR FURTHER INFORMATION CONTACT: A.L.
Craig, Office of Privacy Management,
telephone 202–475–3528, fax 202–372–
8405, or email hqs-dg-m-cg-61-pii@
uscg.mil for questions on these
documents.
SUPPLEMENTARY INFORMATION:
SUMMARY:
E:\FR\FM\28MRN1.SGM
28MRN1
]]>Agencies
[Federal Register Volume 89, Number 61 (Thursday, March 28, 2024)]
[Notices]
[Page 21527]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-06618]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, NIDA.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute on Drug Abuse, including consideration of personnel
qualifications and performance, and the competence of individual
investigators, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, NIDA.
Date: May 7, 2024.
Closed: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Date: May 8, 2024.
Closed: 9:15 a.m. to 3:55 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Date: May 9, 2024.
Closed: 9:30 a.m. to 3:20 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: National Institute on Drug Abuse, NIH, Biomedical
Research Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Contact Person: Megan E. Bollinger, M.S., Management Analyst,
Office of the Scientific Director, National Institute on Drug Abuse,
251 Bayview Boulevard, Suite 200, Baltimore, MD 21224, (443) 740-
2466, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: March 25, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-06618 Filed 3-27-24; 8:45 am]
BILLING CODE 4140-01-P
